InterMune Inc Share Price
Equities
US45884X1037
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2014 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
2014 | Roche : rules out mega deals, open to smaller ones - paper | RE |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Chief Tech/Sci/R&D Officer | 69 | 31/03/02 | |
Carla Fiankan
LAW | General Counsel | - | 31/07/11 |
1st Jan change | Capi. | |
---|---|---|
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+49.90% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- Stock